BCG vaccine nesting birds and rusted electrical conduits. The resulting closure of the plant for over two years resulting in shortages of bladder cancer and tuberculosis vaccines. On October 29, 2014 Health Canada gave the permission for Sanofi to resume production of BCG. The global supply situation was analyzed in 2017 and concluded that the global supply is sufficient to meet forecasted BCG vaccine demand but risks for shortages remain mainly due to supply concentration. A weakened strain of bovine tuberculosis bacillus, "Mycobacterium bovis" is specially subcultured in a culture medium, usually Middlebrook 7H9. Some BCG vaccines are freeze dried and become
Belarusian Railway BCG-1 Belarusian Railway BCG-1 The Belarusian Railways BCG-1, originally Belarusian Railways BKG-1 (БКГ : "Белорусско-Китайский Грузовой"), is a type of twin-unit, eight axle, (Bo'Bo')-(Bo'Bo'), high power mainline electric freight locomotive manufactured by CNR Datong Electric Locomotive for the Belarusian Railway. The locomotives are derived from the China Railways HXD2 locomotive type developed from the Alstom Prima locomotive platform. In April 2010 CNR Datong announced that it had obtained a 700million Yuan contract to supply 12 twin section electric locomotives to Belarus; the locomotives were to be used to increase haulage capacity from the 4700t to 5500t capacity of the 6.52MW VL80S